Recent Updates
Recently added Catalysts
ALVO Negative Sentiment Score: 25/100

Alvotech Investigated For Potential Securities Law Violations by Block & Leviton LLP; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Key Takeaway: Alvotech (NASDAQ: ALVO) is being investigated by Block & Leviton for potential violations of securities laws following a complete response letter issued by the FDA. This letter pertains to the company's Biologics License Application for AVT02, a biosimilar candidate for Humira. As a consequence, Alvotech's stock plummeted by over 20% shortly after the announcement. Block & Leviton encourages investors who suffered losses to reach out for possible recovery options.

Market Sentiment Analysis

CONCERNS & RISKS

  • Alvotech is under investigation for potential securities law violations, which raises concerns for investors.
  • The company's stock price dropped more than 20% following the FDA's complete response letter regarding the approval of AVT02.
  • There are deficiencies associated with Alvotech's manufacturing facility that need to be resolved before the FDA can approve the application.

Full Press Release Details

BOSTON, May 03, 2023 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Alvotech (NASDAQ: ALVO) for potential securities law violations. Investors who have lost money in their Alvotech investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/alvo.
What is this all about?
On April 13, 2023, after the market closed, “Teva Pharmaceutical Industries Ltd. (TEVA) announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) to its partner Alvotech (ALVO) for the Biologics License Application (BLA) for AVT02, a high-concentration biosimilar candidate for Humira® (adalimumab). The CRL stated that the application could not be approved at this time based on deficiencies associated with Alvotech’s manufacturing facility that must be satisfactorily resolved. Additional review of the details following the recent FDA’s re-inspection and CRL are being assessed to determine next steps.”
Shares of Alvotech dropped more than 20% in early morning trading on April 14, 2023.
Anyone who purchased Alvotech stock and has lost money may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.
What is Block & Leviton doing?
Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.
What should you do next?
If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at cases@blockleviton.com, or by phone at (617) 398-5600.
Why should you contact Block & Leviton?
Many law firms may issue press releases about this matter; most of those firms do not actually litigate securities class actions. Block & Leviton is a law firm that actually litigates cases. We are dedicated to obtaining significant recoveries on behalf of defrauded investors through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website, www.blockleviton.com, or call (617) 398-5600 or email cases@blockleviton.com with any questions.
This notice may constitute attorney advertising.
260 Franklin St., Suite 1860
Phone: (617) 398-5600
SOURCE: Block & Leviton LLP

Tags

Complete Response Letter

Frequently Asked Questions

What is Alvotech being investigated for?

Alvotech is under investigation for potential securities law violations following a FDA complete response letter.

Why did Alvotech's stock price drop?

Shares of Alvotech fell over 20% after the FDA issued a complete response letter regarding its biosimilar application.

How can investors recover losses?

Investors who lost money in Alvotech can contact Block & Leviton for assistance in recovering losses.

What does Block & Leviton do?

Block & Leviton investigates potential securities law violations and litigates cases for investor recovery.

How to contact Block & Leviton?

Contact Block & Leviton via email at cases@blockleviton.com or call (617) 398-5600.

Last updated: May 3, 2023